KH Neochem Co., Ltd.
TSE:4189.T
2024 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 115,217 | 114,880 | 117,110 | 77,332 | 94,209 | 101,199 | 94,661 | 80,163 | 103,478 | 143,488 |
| Cost of Revenue
| 93,279 | 90,434 | 84,876 | 61,187 | 73,409 | 79,210 | 71,997 | 61,413 | 86,952 | 129,692 |
| Gross Profit
| 21,938 | 24,446 | 32,234 | 16,145 | 20,800 | 21,989 | 22,664 | 18,750 | 16,526 | 13,796 |
| Gross Profit Ratio
| 0.19 | 0.213 | 0.275 | 0.209 | 0.221 | 0.217 | 0.239 | 0.234 | 0.16 | 0.096 |
| Reseach & Development Expenses
| 939 | 871 | 1,005 | 919 | 847 | 822 | 939 | 898 | 973 | 0 |
| General & Administrative Expenses
| 10,896 | 0 | 0 | 0 | 3,827 | 3,889 | 3,893 | 3,289 | 3,399 | 7,694 |
| Selling & Marketing Expenses
| 1,095 | 1,071 | 1,420 | 1,095 | 1,213 | 1,262 | 1,227 | 1,057 | 1,113 | 3,296 |
| SG&A
| 11,991 | 1,071 | 1,420 | 1,095 | 1,213 | 1,262 | 1,227 | 1,057 | 1,113 | 10,990 |
| Other Expenses
| -71 | 10,916 | 11,126 | 9,405 | 10,025 | 179 | 303 | -11 | -460 | 0 |
| Operating Expenses
| 11,991 | 11,987 | 12,546 | 10,500 | 11,238 | 11,128 | 11,167 | 9,765 | 10,263 | 9,636 |
| Operating Income
| 9,947 | 12,456 | 19,685 | 5,642 | 9,559 | 10,858 | 11,495 | 8,982 | 6,261 | 2,806 |
| Operating Income Ratio
| 0.086 | 0.108 | 0.168 | 0.073 | 0.101 | 0.107 | 0.121 | 0.112 | 0.061 | 0.02 |
| Total Other Income Expenses Net
| -222 | -822 | 103 | -15 | 337 | -1,106 | 485 | -34 | 4,614 | 1,139 |
| Income Before Tax
| 9,725 | 11,634 | 19,788 | 5,627 | 9,896 | 9,754 | 11,982 | 8,950 | 10,877 | 3,945 |
| Income Before Tax Ratio
| 0.084 | 0.101 | 0.169 | 0.073 | 0.105 | 0.096 | 0.127 | 0.112 | 0.105 | 0.027 |
| Income Tax Expense
| 2,795 | 3,382 | 5,924 | 1,481 | 2,850 | 2,869 | 3,672 | 2,715 | 3,005 | 1,137 |
| Net Income
| 6,826 | 8,073 | 13,691 | 4,046 | 6,917 | 6,737 | 8,167 | 6,013 | 7,712 | 2,604 |
| Net Income Ratio
| 0.059 | 0.07 | 0.117 | 0.052 | 0.073 | 0.067 | 0.086 | 0.075 | 0.075 | 0.018 |
| EPS
| 184.23 | 217.74 | 368.95 | 109.12 | 187.07 | 182.76 | 222.12 | 173.56 | 226.54 | 76.59 |
| EPS Diluted
| 184.23 | 217.74 | 368.95 | 109.02 | 186.42 | 181.62 | 220.44 | 172.23 | 226.54 | 76.59 |
| EBITDA
| 14,598 | 17,473 | 24,800 | 10,112 | 13,593 | 14,762 | 15,610 | 12,790 | 10,355 | 935 |
| EBITDA Ratio
| 0.127 | 0.152 | 0.212 | 0.131 | 0.144 | 0.146 | 0.165 | 0.16 | 0.1 | 0.007 |